RENIBUS THERAPEUTICS
Renibus Therapeutics operates in the healthcare industry focusing on the pharmaceutical business. The company was incorporated in 2015 and is based in Lantana, Texas.
RENIBUS THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Lantana, Florida, United States
Country:
United States
Website Url:
http://www.renibus.com
Total Employee:
1+
Status:
Active
Contact:
(469)688-3174
Total Funding:
45.92 M USD
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Centrexion
Centrexion operates in the healthcare industry, focusing on the biotechnology business.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Zeno Pharm
Zeno Pharm operates in the healthcare industry focusing on the pharmaceutical business.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | Renibus Therapeutics Expands Leadership Team, Announces Appointments of New Chief Financial Officer and Chief Medical Officer |
Official Site Inspections
http://www.renibus.com Semrush global rank: 6.64 M Semrush visits lastest month: 907
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Renibus Therapeutics"
About Us - Renibus Therapeutics
Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving, and extending patients’ lives by developing products to prevent disease progression, improve …See details»
Renibus Therapeutics - Crunchbase Company Profile
Renibus Therapeutics is a clinical-stage biotech company transforming outcomes in cardiothoracic surgical patients. It has developed a portfolio of products that activate multiple cytoprotective pathways, including organ protection via …See details»
Renibus Announces Leadership Transition - PR Newswire
SOUTHLAKE, Texas, March 21, 2024 /PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio …See details»
Renibus Therapeutics Inc - LinkedIn
Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease progression,...See details»
Our Approach - Renibus Therapeutics
We have a robust pipeline of programs to prevent disease progression, improve outcomes and protect against organ damage in cardio, renal and metabolic diseases. Our Approach Developing breakthrough products.See details»
Renibus Therapeutics Expands Leadership Team, Announces …
Southlake, Texas, June 2, 2022 – Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today announced …See details»
Renibus Therapeutics Expands Leadership Team, …
Jun 2, 2022 · Renibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention and treatment of kidney disease.See details»
Renibus Therapeutics - Overview, News & Similar companies
Mar 21, 2024 · Renibus Therapeutics contact info: Phone number: (682) 285-1711 Website: www.renibus.com What does Renibus Therapeutics do? Renibus Therapeutics was found in …See details»
Renibus Therapeutics names Keyser as president, CEO
Mar 25, 2024 · Renibus Therapeutics, a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal and metabolic diseases, today announced a …See details»
Contact Us - Renibus Therapeutics
Renibus Therapeutics Inc. 181 Grand Ave, Suite 225, Southlake, TX 76092. General Inquiries 682-285-1711. Business Development: [email protected] " *See details»
Renibus Therapeutics Expands Leadership Team, …
SOUTHLAKE, Texas, June 02, 2022 (GLOBE NEWSWIRE) -- Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today...See details»
Jamie A. Donadio - CFO at Rénibus Therapeutics | The Org
Jamie A. Donadio has served as acting Chief Financial Officer of Renibus since January 2022. Mr. Donadio holds over 20 years of finance and accounting experience, including 19 years at …See details»
Frontier Scientific Develops and Provides Process to Produce …
Jun 23, 2020 · Renibus is investigating the ability of RBT-9 both to inhibit viral activity and to prevent organ failure in COVID-19 patients. For more information visit …See details»
Renibus Therapeutics Announces Appointment of Frank …
Feb 10, 2022 · Southlake, Texas, February 15, 2022 – Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal …See details»
Renibus Therapeutics Raises $33 Million Bridge Financing to …
Nov 14, 2022 · Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients' lives by developing breakthrough products to prevent …See details»
Cascade Chemistry Selected to Produce Active ... - Business Wire
Jun 16, 2020 · Renibus Therapeutics is developing a novel anti-viral therapy, RBT-9 (stannous protoporphyrin--SnPP), for the treatment of COVID-19 in early stage patients who are …See details»
Renibus Presents Phase 2 Results on RBT-1, a First-in-Class ...
Sep 11, 2023 · Renibus is advancing RBT-1 toward Phase 3 development for its lead indication to reduce post-operative complications following cardiothoracic surgery.See details»
Renibus Therapeutics Initiates Phase 2 Study of RBT-1 for …
DALLAS, Texas, March 11, 2021 (GLOBE NEWSWIRE) -- Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention, treatment, and diagnostic testing of …See details»
Rapid and Intensive Guideline-Directed Medical Therapy for Heart ...
Aug 5, 2024 · Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, et al. Safety, tolerability and efficacy of up-titration of …See details»
Renibus Therapeutics Announces Appointment of Frank
SOUTHLAKE, Texas, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of …See details»